Optical Imaging Market

Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027

Report Code: MD 2818 Feb, 2023, by marketsandmarkets.com

The global optical imaging market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to grow at a CAGR of 13.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Optical imaging is a rapidly developing field that has significantly impacted the global healthcare industry by facilitating effective and affordable healthcare. Factors such as the increased glaucoma and cataract cases among elderly population, increasing applications of optical imaging techniques in drug discovery processes and preclinical research, and rapid increased in geriatric populace across the world are fueling the growth of this market.

Global Optical imaging Trends

Optical Imaging Market

To know about the assumptions considered for the study, Request for Free Sample Report

Optical imaging Market Dynamics

DRIVERS: Increasing prevalence of eye disorders due to the rising geriatric population

The growing prevalence of eye disorders, owing to the rising global geriatric population, is one of the key factors driving the growth of the global market. The tear layer loses stability and degrades faster in the elderly, making them more prone to eye disorders. Therefore, the risk of getting severe eye disorders increases significantly with age, particularly after 60 years. Currently, the prevalence rate of glaucoma is four times higher in individuals aged 80 years and above as compared to those aged 40 years and above. Also, the prevalence rates of several other eye disorders, such as cataract, presbyopia, and age-related macular degeneration (AMD), is increasing across the globe. For instance, according to Prevent Blindness (US), 24.41 million people were suffering from cataracts in the US in 2010; this number is expected to increase to 50.0 million by 2050.

RESTRAINTS: Reimbursement challenges

The US is the largest market for optical imaging technologies. However, recent changes in reimbursement policies in the country are expected to affect the growth of this market. With the implementation of the Affordable Care Act (ACA), the size of the insured population in the US has increased. However, this has also resulted in insufficient reimbursements for newly insured patients. Moreover, medical reimbursements for various optical imaging technologies are decided based on their use for intended applications.

In July 2020, the Centers for Medicare, and Medicaid Services (CMS) implemented major changes in reimbursements for several vitreoretinal procedures. They implemented a 15% reimbursement cut for all cataract surgeries performed within the US. Thus, reimbursement changes pose a great barrier to the market growth.

OPPORTUNITIES: Emerging economies

Emerging countries such as India, China, Japan, and Brazil are expected to provide significant growth opportunities for players operating in the global market. These countries are some of the fastest-growing economies in the world. According to estimates from the World Economic Forum, 2020, these emerging economies contributed to around one-third of the global healthcare expenditure. The rise in geriatric population and diseases associated with it are also certain factors that create high growth opportunities for the market.

CHALLENGES: Sustainability of small and medium-sized players

Increasing market competitiveness is one of the major challenges in the optical imaging systems market, especially for small and mid-tier companies. Although the global market is dominated by few players such as PerkinElmer, Inc., Carl Zeiss Meditec AG, and Abbott Laboratories, new entrants and mid-tier firms continuously strive to garner a greater market share and market visibility. However, higher costs and longer time required for the development of optical imaging products pose a major barrier for such companies.

Market Overview - Executive Summary

In this report, the optical imaging market is segmented on the basis of product, application, end users, therapeutic area, technique and region.

Optical Coherence Tomography segment accounted for the largest share in the optical imaging market by technique

The demand for better techniques and safer diagnostic procedures is rising as a result of changes in the medical technology sector. The demand for non-invasive diagnostic imaging modalities is driven by factors such as increasing elderly population, an increase in the prevalence of chronic diseases, and the need for safer diagnostic methods. This in turn fuels the market's expansion. OCT systems enables the visualisation of optically scattered, non transparent tissues, making it a useful tool for the diagnosis in various therapeutic areas.

Ophthalmology segment accounted for the largest share in the optical imaging market by therapeutic area

The market's overall growth for ophthalmology is likely to be driven by the growing number of ophthalmic procedures being performed every year across the globe. Nearly 3.7 million cataract procedures are performed in the US, 7 million in Europe and 20 million worldwide.  With the increased awareness of optical instruments in the developing countries, the market provides great growth opportunity in these regions. Growing demand for low cost OCT systems is creating opportunities for the market to flourish in this region. This trend is expected to continue in the coming years and contribute to overall market growth. The increasing aging population, coupled with the rising prevalence of ophthalmic disorders, will play a vital role in the growth of the global market during the forecast period

Imaging systems segment accounted for the largest share in the optical imaging market by product

The imaging systems segment accounted for the largest share of the global market, by product in the forecast period. This segment's large share can be attributed to its wide application in ophthalmology, oncology, and other application. These systems are widely adopted as they provide real-time, 1D depth, 2D cross-sectional, and 3D volumetric images with micron-level resolution and imaging depths of up to a few millimeters with no hazardous radiation. Subsurface tissue details are hidden without OCT display in bright and sharp images, allowing for a better understanding of ocular pathology. In turn, this development helps surgeons overcome uncertainties during eye surgeries to achieve the best possible patient outcome.

Hospital segment accounted for the largest share in the optical imaging market by end user

Based on end user, the market, by end user is led by the hospital and clinics segment Hospitals and clinics majorly adopt optical imaging technologies for ophthalmological diagnostic imaging and cancer screening procedures. These technologies are also used in cardiology, neurology, and dermatology, but to a lesser extent. This market's growth is mainly driven by the increasing clinical applications of optical imaging techniques in various therapeutic areas and the growing demand for optical imaging products by clinicians across the globe.

Geographic Snapshot: Optical Imaging Market

Optical Imaging Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Optical imaging Market: Carl Zeiss Meditec (Germany), Abbott (US), Topcon Corporation (Japan), Canon (Japan), PerkinElmer (US), Koninklijke Philips (Netherlands), Heidelberg Engineering (US), Leica Microsystems (Germany), Headwall Photonics (US), Visionix (US), Optical Imaging (Israel), Optos (Scotland), Wasatch Photonics (US), ArcScan (US), DermaLumics (Spain), Cylite (Australia), MOPTIM (Guangdong), Michelson Diagnostics (England), Thorlabs (US), Hamamatsu Photonics (Japan), iTheraMedical (Germany), Kibero (Germany), Seno Medical (US), Aspectus Imaging (Germany), and Agfa-Gevaert (Belgium).

Optical Imaging Market Report Scope:

Report Metric

Details

Market Size available for years

2020-2027

Base Year Considered

2021

Forecast period

2022-2027

Forecast Unit

Value(USD Billion)

Segments covered

Product, Application, Therapeutic Area, Techniques and End User

Geographies covered

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and  Africa

Companies Covered

Carl Zeiss Meditec (Germany), Abbott (US), Topcon Corporation (Japan), Canon (Japan), PerkinElmer (US), Koninklijke Philips (Netherlands), Heidelberg Engineering (US), Leica Microsystems (Germany), Headwall Photonics (US), Visionix (US), Optical Imaging (Israel), Optos (Scotland), Wasatch Photonics (US), ArcScan (US), DermaLumics (Spain), Cylite (Australia), MOPTIM (Guangdong), Michelson Diagnostics (England), Thorlabs (US), Hamamatsu Photonics (Japan), iTheraMedical (Germany), Kibero (Germany), Seno Medical (US), Aspectus Imaging (Germany), and Agfa-Gevaert (Belgium).

The research report categorizes the optical imaging market into the following segments & sub-segments:

By Product

  • Imaging Systems
  • Camera
  • Software
  • Lenses
  • Illuminating Systems
  • Other

By Application

  • Pathological Imaging
  • Intraoperative Imaging

By End User

  • Hospitals
  • Research Laboratories
  • Pharmaceutical and Biotechnology Companies

By Therapeutic Area

  • Ophthalmology
  • Oncology
  • Cardiology
  • Dermatology
  • Neurology
  • Others

By Technique

  • Optical Coherence Tomography
  • Near infrared Spectroscopy
  • Hyperspectral Imaging
  • Photoacoustic Tomography

By Region

  • North America North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa

Recent Developments:

  • In January 2023, Canon Medical Inc., partnered with ScImage. The strategic partnership between the two companies will directly broaden and advance Canon Medical Systems’ outreach in hemodynamics with the Fysicon QMAPP Hemo portfolio (Fysicon is a Canon Medical subsidiary). As a result, Canon Medical plans to increase its presence in the cardiac market, offering innovative solutions and unique business models tailored to each client’s specific needs.
  • In August 2021, Topcon partnered with RetInSight to develop a seamless interface between RetInSight’s AI-assisted retinal biomarker applications and Topcon’s market-leading OCT devices and cloud-based data management solution, Harmony.
  • In December 2020, Carl Zeiss acquired arivis to further strengthen its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 33)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION & SCOPE 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKETS COVERED 
FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
    1.7 SUMMARY OF CHANGES 
    1.8 IMPACT OF RECESSION 

2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 9 COUNTRY-LEVEL ANALYSIS OF GLOBAL MARKET
          FIGURE 10 APPROACH 4: TOP-DOWN APPROACH
          FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MARKET
          FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ASSUMPTIONS 
    2.5 ASSUMPTIONS 
 
3 EXECUTIVE SUMMARY (Page No. - 51)
    FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 GLOBAL MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GLOBAL MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 GLOBAL MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION)
    FIGURE 18 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 19 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
 
4 PREMIUM INSIGHTS (Page No. - 55)
    4.1 GLOBAL MARKET OVERVIEW 
          FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN GLOBAL MARKET
    4.2 NORTH AMERICA: MARKET, BY APPLICATION AND COUNTRY 
          FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021
    4.3 REGIONAL MIX: GLOBAL MARKET 
          FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    4.4 GLOBAL MARKET: REGIONAL SNAPSHOT 
          FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 58)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders
                                FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION
                                TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION)
                    5.2.1.2 Technological innovations
                    5.2.1.3 Growing application areas of optical imaging techniques
                    5.2.1.4 Growing need to minimize use of radiation technologies
                                TABLE 2 KEY MARKET DRIVERS
           5.2.2 RESTRAINTS
                    5.2.2.1 Reimbursement challenges
                    5.2.2.2 Lack of skilled operators
                                TABLE 3 KEY MARKET RESTRAINTS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Expansion and market penetration opportunities in emerging economies
                                TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060
                    5.2.3.2 Growing applications in pharmaceutical & biotechnology research
                                TABLE 5 KEY MARKET OPPORTUNITIES
           5.2.4 CHALLENGES
                    5.2.4.1 Sustainability of small and medium-sized players
                    5.2.4.2 High cost of optical imaging procedures and extensive data requirements
                                TABLE 6 KEY MARKET CHALLENGES
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          FIGURE 26 PORTER’S FIVE FORCES ANALYSIS
          TABLE 7 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT FROM NEW ENTRANTS
           5.3.2 THREAT FROM SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 27 GLOBAL MARKET: VALUE CHAIN ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS 
          FIGURE 28 GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
    5.6 REGULATORY ANALYSIS 
          TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS, 
                               BY REGION 71
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                                TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
                    5.6.1.2 Canada
                                TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.6.2 EUROPE
           5.6.3 ASIA PACIFIC
                    5.6.3.1 Japan
                                TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.6.3.2 China
                                TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.6.3.3 India
    5.7 PATENT ANALYSIS 
    5.8 PRICING ANALYSIS 
    5.9 TRADE DATA 
           5.9.1 US
                    TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020
           5.9.2 CHINA
           5.9.3 UK
           5.9.4 INDIA
 
6 OPTICAL IMAGING MARKET, BY PRODUCT (Page No. - 78)
    6.1 INTRODUCTION 
          TABLE 14 GLOBAL MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 IMAGING SYSTEMS 
          TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 OPTICAL IMAGING SYSTEMS
                    6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth
                                TABLE 17 KEY OPTICAL IMAGING SYSTEMS
                                TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 SPECTRAL IMAGING SYSTEMS
                    6.2.2.1 Growing need for advanced imaging techniques to promote growth
                                TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 CAMERAS 
           6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS
                    TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 SOFTWARE 
           6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH
                    TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 LENSES 
           6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES
                    TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 ILLUMINATION SYSTEMS 
           6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH
                    TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 OTHER PRODUCTS 
          TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 OPTICAL IMAGING MARKET, BY TECHNIQUE (Page No. - 90)
    7.1 INTRODUCTION 
          TABLE 25 GLOBAL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT) 
           7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH
                    TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 NEAR-INFRARED SPECTROSCOPY (NIRS) 
           7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH
                    TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 HYPERSPECTRAL IMAGING (HSI) 
           7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH
                    TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT) 
           7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH
                    TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 OPTICAL IMAGING MARKET, BY APPLICATION (Page No. - 97)
    8.1 INTRODUCTION 
          TABLE 30 GLOBAL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 PATHOLOGICAL IMAGING 
           8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH
                    TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 INTRA-OPERATIVE IMAGING 
           8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET
                    TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA (Page No. - 101)
    9.1 INTRODUCTION 
          TABLE 33 GLOBAL MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
    9.2 OPHTHALMOLOGY 
           9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET
                    TABLE 34 GLOBAL MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 ONCOLOGY 
           9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH
                    TABLE 35 GLOBAL MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 CARDIOLOGY 
           9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET
                    TABLE 36 GLOBAL MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    9.5 DERMATOLOGY 
           9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING
                    TABLE 37 GLOBAL MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    9.6 NEUROLOGY 
           9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH
                    TABLE 38 GLOBAL MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
    9.7 OTHER THERAPEUTIC AREAS 
          TABLE 39 GLOBAL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION)
 
10 OPTICAL IMAGING MARKET, BY END USER (Page No. - 110)
     10.1 INTRODUCTION 
             TABLE 40 GLOBAL MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 HOSPITALS & CLINICS 
             10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET
                        TABLE 41 GLOBAL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
     10.3 RESEARCH LABORATORIES 
             10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH
                        TABLE 42 GLOBAL MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
     10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET
                        TABLE 43 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
 
11 OPTICAL IMAGING MARKET, BY REGION (Page No. - 117)
     11.1 INTRODUCTION 
             FIGURE 29 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 44 GLOBAL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT
                        TABLE 45 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 46 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 48 NORTH AMERICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 49 NORTH AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 50 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 51 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.2 US
                        11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country
                                      TABLE 52 US: MACROECONOMIC INDICATORS
                                      TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 55 US: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 56 US: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 57 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 58 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Availability of research funding to drive growth
                                      TABLE 59 CANADA: MACROECONOMIC INDICATORS
                                      TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 62 CANADA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 63 CANADA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 64 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 65 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: RECESSION IMPACT
                        FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT
                        TABLE 66 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 67 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 69 EUROPE: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 70 EUROPE: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 71 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 72 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Robust healthcare spending to support market in Germany
                                      TABLE 73 GERMANY: MACROECONOMIC INDICATORS
                                      TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 76 GERMANY: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 77 GERMANY: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 78 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 79 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth
                                      TABLE 80 FRANCE: MACROECONOMIC INDICATORS
                                      TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 83 FRANCE: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 84 FRANCE: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 85 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 86 FRANCE: IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 UK
                        11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth
                                      TABLE 87 UK: MACROECONOMIC INDICATORS
                                      TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 90 UK: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 91 UK: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 92 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 93 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Presence of major pharmaceutical & research institutes to drive market
                                      TABLE 94 ITALY: MACROECONOMIC INDICATORS
                                      TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 97 ITALY: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 98 ITALY: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 99 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 100 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Increasing development in biomedical sciences to drive growth
                                      TABLE 101 SPAIN: MACROECONOMIC INDICATORS
                                      TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 104 SPAIN: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 105 SPAIN: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 106 SPAIN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 107 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.7 REST OF EUROPE
                        TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES
                        TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 111 REST OF EUROPE: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 112 REST OF EUROPE: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 113 REST OF EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 114 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT
                        TABLE 115 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 116 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 118 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 119 ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 120 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 121 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Established pharmaceutical & biotechnology research base to propel market
                                      TABLE 122 JAPAN: MACROECONOMIC INDICATORS
                                      TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 125 JAPAN: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 126 JAPAN: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 127 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 128 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth
                                      TABLE 129 CHINA: MACROECONOMIC INDICATORS
                                      TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 132 CHINA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 133 CHINA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 134 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 135 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market
                                      TABLE 136 INDIA: MACROECONOMIC INDICATORS
                                      TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 139 INDIA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 140 INDIA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 141 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 142 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.5 AUSTRALIA
                        11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market
                                      TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS
                                      TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 146 AUSTRALIA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 147 AUSTRALIA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 148 AUSTRALIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 149 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.6 SOUTH KOREA
                        11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth
                                      TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS
                                      TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 153 SOUTH KOREA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 154 SOUTH KOREA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 155 SOUTH KOREA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 156 SOUTH KOREA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                        TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 159 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 160 REST OF ASIA PACIFIC: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 161 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 162 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 164 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 166 LATIN AMERICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 167 LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 168 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 169 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.5.2 BRAZIL
                        11.5.2.1 Improved GDP expenditure on healthcare
                                      TABLE 170 BRAZIL: MACROECONOMIC INDICATORS
                                      TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 173 BRAZIL: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                      TABLE 174 BRAZIL: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                                      TABLE 175 BRAZIL: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 176 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.5.3 REST OF LATIN AMERICA
                        TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 179 REST OF LATIN AMERICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 180 REST OF LATIN AMERICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 181 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 182 REST OF LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
             11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 185 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                        TABLE 186 MIDDLE EAST & AFRICA: MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION)
                        TABLE 187 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 188 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 183)
     12.1 INTRODUCTION 
             FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023)
     12.2 REVENUE SHARE ANALYSIS 
             FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET
     12.3 MARKET SHARE ANALYSIS 
             FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GLOBAL MARKET, 2021
     12.4 COMPANY EVALUATION QUADRANT 
             12.4.1 STARS
             12.4.2 EMERGING LEADERS
             12.4.3 PERVASIVE PLAYERS
             12.4.4 PARTICIPANTS
                        FIGURE 36 GLOBAL MARKET: GLOBAL COMPANY EVALUATION QUADRANT
     12.5 START-UP/SME EVALUATION QUADRANT 
             12.5.1 PROGRESSIVE COMPANIES
             12.5.2 STARTING BLOCKS
             12.5.3 RESPONSIVE COMPANIES
             12.5.4 DYNAMIC COMPANIES
                        FIGURE 37 GLOBAL MARKET: GLOBAL START-UP/SME MATRIX
     12.6 COMPETITIVE BENCHMARKING 
             12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS
             12.6.2 PRODUCT FOOTPRINT
             12.6.3 TECHNIQUE FOOTPRINT
             12.6.4 THERAPEUTIC AREA FOOTPRINT
             12.6.5 REGIONAL FOOTPRINT
     12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS 
             FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS
     12.8 COMPETITIVE SITUATION AND TRENDS 
             12.8.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 189 GLOBAL MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023)
             12.8.2 DEALS
                        TABLE 190 GLOBAL MARKET: DEALS(JANUARY 2019 TO JANUARY 2023)
             12.8.3 OTHER DEVELOPMENTS
                        TABLE 191 GLOBAL MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023)
 
13 COMPANY PROFILES (Page No. - 200)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 CARL ZEISS MEDITEC AG
                        TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW
                        FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
             13.1.2 TOPCON CORPORATION
                        TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.3 CANON INC.
                        TABLE 194 CANON INC.: BUSINESS OVERVIEW
                        FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021)
             13.1.4 ABBOTT LABORATORIES INC.
                        TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021)
             13.1.5 KONINKLIJKE PHILIPS N.V.
                        TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
             13.1.6 PERKINELMER, INC.
                        TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW
                        FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
             13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION)
                        TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW
                        FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.8 AGFA-GEVAERT N.V.
                        TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW
                        FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021)
             13.1.9 HAMAMATSU PHOTONICS K.K.
                        TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW
                        FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021)
     13.2 OTHER PLAYERS 
             13.2.1 HEIDELBERG ENGINEERING, INC.
                        TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW
             13.2.2 HEADWALL PHOTONICS, INC.
                        TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW
             13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.)
                        TABLE 203 VISIONIX: BUSINESS OVERVIEW
             13.2.4 OPTICAL IMAGING LTD.
                        TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW
             13.2.5 OPTOS
                        TABLE 205 OPTOS: BUSINESS OVERVIEW
             13.2.6 WASATCH PHOTONICS
                        TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW
             13.2.7 ARCSCAN INC.
                        TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW
             13.2.8 DERMALUMICS
                        TABLE 208 DERMALUMICS: BUSINESS OVERVIEW
             13.2.9 CYLITE PTY LTD.
                        TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW
             13.2.10 MOPTIM
                        TABLE 210 MOPTIM: BUSINESS OVERVIEW
             13.2.11 MICHELSON DIAGNOSTICS LTD.
                        TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW
             13.2.12 THORLABS
                        TABLE 212 THORLABS: BUSINESS OVERVIEW
             13.2.13 ITHERAMEDICAL
                        TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW
             13.2.14 KIBERO
                        TABLE 214 KIBERO: BUSINESS OVERVIEW
             13.2.15 SENO MEDICAL
                        TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW
             13.2.16 ASPECTUS IMAGING
                        TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 249)
     14.1 INSIGHTS FROM INDUSTRY EXPERTS 
     14.2 DISCUSSION GUIDE 
     14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.4 CUSTOMIZATION OPTIONS 
     14.5 RELATED REPORTS 
     14.6 AUTHOR DETAILS 

This study involved four major approaches in estimating the current optical imaging market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the optical imaging market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Some of the key secondary resources referred to in this study include:

  • The United States Department of Health & Human Services (HHS)
  • Center for Drug Evaluation and Research (CDER)
  • Center for Disease Control and Prevention
  • National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  • Center for Devices & Radiological Health
  • World Health Organisation
  • American Hospital Association
  • U.S. Bureau of Labor Statistics

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer optical imaging products. Primary sources from the demand side include industry experts such as hospital directors, research professionals, pharmaceutical company research and development head, and other medical professionals.

Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.

Market Size Estimation

The total size of the optical imaging market was arrived at after data triangulation from four different approaches, as mentioned below.

Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

Country level Analysis: The size of the global market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of optical imaging products in the overall market was obtained from secondary data and validated by primary participants to arrive at the total market. Primary participants further validated the numbers.

Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall optical imaging market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Breakdown of Primary Interviews (Supply Side): By End-User Type, Designation, and Region

Optical Imaging Market Size, and Share

* Others include sales managers, marketing managers, and product managers

Note: Tiers of companies are defined by their total revenues; as of 2020, Tier 1>= USD 500 million, Tier 2 = USD 200 million to USD 500 million, and Tier 3<= USD 200 million

To know about the assumptions considered for the study, download the pdf brochure

Breakdown of Primary Interviews (Demand Side): By End-User Type, Designation, and Region

Optical Imaging Market Size, and Share

Note: Other designation includes type-c executives of hospitals and clinics.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

Approach to derive the market size and estimate market growth

The market rankings for leading players were ascertained after a detailed assessment of their revenues from the optical imaging business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

Objectives of the Study

  • To define, describe, and forecast the optical imaging market by product, application, end user, therapeutic area, techniques, and region.
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the global market with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their market shares and core competencies in the global market
  • To track and analyze competitive developments such as partnerships, agreements, acquisitions, product launches, and expansions in the global market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific optical imaging market into Thailand, New Zealand, and other countries.
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 2818
Published ON
Feb, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Optical Imaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback